Bruce Culleton - 03 Dec 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: PROK
Reported as of: 03 Dec 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Dec 2023, 16:04:57 UTC
Prior SEC filing: 03 Aug 2023
Next SEC filing: 16 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Todd Girolamo, attorney in fact

Key filing fact

Bruce Culleton filed Form 4 for PROKIDNEY CORP. (PROK) on 05 Dec 2023.

Key facts

This page summarizes Bruce Culleton's Form 4 filing for PROKIDNEY CORP. (PROK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Dec 2023, 16:04.

Change

Previous filing in this sequence was filed on 03 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PROK transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +2,000,000
Change %
Price: $0.000000
Shares after: 2,000,000
Date: 03 Dec 2023
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 2,000,000
Exercise price: $1.69
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Exercise Price is equal to the greater of (i) the thirty day average stock price of the Company's Class A Ordinary Shares on the Nasdaq Stock Market ("Nasdaq") as of the date of grant (the "Grant Date") and (ii) the closing price of the Company's Class A Ordinary Shares on Nasdaq as of the Grant Date.

Footnote F2

The option vests 25% on the first anniversary of November 15, 2023 and the remaining 75% vests in substantially equal quarterly installments over the following 36 months on each quarterly anniversary of November 15, 2023, subject to continued employment through each such vesting date.